Dialectic cover image

15: D.A. Wallach - Serendipity & Systems

Dialectic

00:00

Investing in Uncertainty: The Evolution of Drug Development

This chapter examines the challenges and considerations of investing in emerging health technologies, especially in biotech sectors like gene editing. It contrasts established treatments with innovative therapies, focusing on the complexities of drug development and the significant breakthroughs in GLP-1 drugs.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app